https://www.selleckchem.com/products/cbd3063.html
Bacillus Calmette-Guerin (BCG), the only available vaccine for tuberculosis (T, has been applied for decades. The Indonesian government recently introduced a national TB disease control programme that includes several action plans, notably enhanced vaccination coverage, which can be strengthened through underpinning its favourable cost-effectiveness. We designed a Markov model to assess the cost-effectiveness of Indonesia's current BCG vaccination programme. Incremental cost-effectiveness ratios (ICERs) were evaluated from the perspec
Like
Comment
Share
